• Totaligent closed the previously disclosed acqui-hire of Aetherium Medical’s platform and team, under a definitive agreement signed April 15, 2026.
• A new wholly owned unit, Aetherium Med One, received Aetherium’s contributed assets, giving Totaligent ownership and immediate operating access to the platform’s core intangible assets.
• Aetherium provides infrastructure linking biotechnology developers to patients via compliant medical-tourism channels in Asia-Pacific, with a focus on cold-chain logistics and commercialization services.
• Aetherium founder Ivan Klarich joined Totaligent as president and a board member following the closing.
• Totaligent also flagged progress toward its previously announced joint venture with GloMed Solutions, which it expects to close within a week.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Totaligent Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605200805PRIMZONEFULLFEED9723672) on May 20, 2026, and is solely responsible for the information contained therein.